消融与微创技术在小肾肿瘤治疗中的作用
本文综述2000年以来关于小肾肿瘤局部治疗(包括经皮消融)安全性与疗效的文献,共纳入64篇文章。射频消融与冷冻治疗是最广泛使用的术式,其中期肿瘤学结局与手术系列相当;成本效益似乎极佳,副作用似乎可接受。迄今尚无比较经皮局部治疗与标准手术或主动监测的随机试验。
要点
- 射频消融与冷冻治疗是使用最广泛的消融术式,中期肿瘤学结局与手术系列相当。
- 对于小于3cm的肿瘤,消融治疗的肿瘤学效果与肾部分切除术相当。
- 经皮消融相比微创肾部分切除术并发症更少、术后恢复更好;尚无随机试验比较其与标准手术或主动监测。
核心结论
- 局部消融治疗现已被接受为小肾肿瘤的有效治疗方法。
- 对于小于3cm的肿瘤,消融治疗的肿瘤学效果与肾部分切除术相当。
- 经皮消融相比微创肾部分切除术并发症更少、术后恢复更好。
研究设计与样本
- 本文为文献综述,检索PubMed与Medline数据库,纳入2000年以来发表的关于小肾肿瘤局部治疗的研究,最终选取并讨论64篇文章。
主要发现
- 射频消融与冷冻治疗是最广泛使用的术式,其中期肿瘤学结局与手术系列相当。
- 消融治疗的成本效益似乎极佳,副作用似乎可接受。
- 迄今尚无比较经皮局部治疗与标准手术方式或主动监测的随机试验。
关键数值与推荐
- 对于小于3cm的肿瘤,消融治疗的肿瘤学效果与肾部分切除术相当。
- 经皮消融相比微创肾部分切除术并发症更少、术后恢复更好。
临床怎么用
- 原文未据此给出推荐。
- 局部消融治疗现已被接受为小肾肿瘤的有效治疗方法。
局限性
- 迄今尚无比较经皮局部治疗与标准手术方式或主动监测的随机试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Nephron-sparing approaches are increasingly recommended for incidental small renal masses. Herein, we review the current literature regarding the safety and efficacy of focal therapy, including percutaneous ablation, for small renal masses. OBJECTIVE: To summarize the application of ablative therapy in the management of small renal masses. EVIDENCE ACQUISITION: PubMed and Medline database search was performed to look for findings published since 2000 on focal therapy for small renal masses. After literature review, 64 articles were selected and discussed. EVIDENCE SYNTHESIS: Radiofrequency ablation and cryotherapy are the most widely used procedures with intermediate-term oncological outcome comparable with surgical series. Cost effectiveness seems excellent and side effects appear acceptable. To date, no randomized trial comparing percutaneous focal therapy with standard surgical approach or active surveillance has been performed. CONCLUSIONS: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy. Percutaneous ablation has fewer complications and a better postoperative profile when compared with minimally invasive partial nephrectomy. PATIENT SUMMARY: Focal ablative therapies are now accepted as effective treatment for small renal tumors. For tumors <3cm, oncological effectiveness of ablative therapies is comparable with that of partial nephrectomy.
引用
- Salagierski M, Wojciechowska A, Zając K, et al. The Role of Ablation and Minimally Invasive Techniques in the Management of Small Renal Masses. Eur Urol Oncol. 2018. PMID: 31158078. doi:10.1016/j.euo.2018.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。